Department of Surgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Department of Surgery, Xingtai People's Hospital, Hebei Medical University, Xingtai, Hebei, China.
J Int Med Res. 2021 Nov;49(11):3000605211051581. doi: 10.1177/03000605211051581.
To investigate Krüppel-like factor 17 () expression in normal and gastric cancer tissues and cell lines.
Levels of KLF17 mRNA and protein in GES-1 normal gastric mucosal cells, and NCI-N87, SGC-7901, BGC-823 and HGC-27 gastric cancer cells were analysed by quantitative polymerase chain reaction (qPCR) and western blot. Differences in expression between gastric cancer and adjacent tissues were analysed by qPCR and immunohistochemistry. Invasion/migration effects of overexpression in BGC-823 and HGC-27 cells were analysed by wound-healing and Transwell chamber assays. Changes in expression of and epithelial-mesenchymal transition (EMT)-related genes (matrix metalloproteinase [MMP]-9, vimentin and E-cadherin) were analysed in BGC-823 and HGC-27 cells before and after transfection using qPCR and western blot. Transforming growth factor (TGF)-β1, Smad family member (Smad)2/3 and phosphorylated-Smad2/3 levels in BGC-823 and HGC-27 cells were assessed by qPCR and western blot.
expression was lower in gastric cancer versus adjacent tissues, and in gastric cancer cell lines versus GES-1 normal gastric mucosal cells, and was positively correlated with degree of cancer-cell differentiation. Wound-healing and Transwell assays showed decreased migration and invasion ability of BGC-823 and HGC-27 cells transfected to overexpress . overexpression was associated with decreased MMP-9 and vimentin in BGC-823 and HGC-27 cancer cells, and increased KLF17 and E-cadherin. overexpression also resulted in decreased levels of TGF-β1 and p-Smad2/3 in BGC-823 and HGC-27 cancer cells.
is poorly expressed in gastric cancer tissues and cell lines. overexpression might inhibit EMT via the TGF-β/Smad pathway, thereby reducing gastric cancer cell invasion and migration. Therefore, KLF17 may become a novel target for treating gastric cancer.
研究 Krüppel 样因子 17()在正常胃组织和胃癌组织及细胞系中的表达。
采用实时定量聚合酶链反应(qPCR)和蛋白质印迹法检测 GES-1 正常胃黏膜细胞和 NCI-N87、SGC-7901、BGC-823 和 HGC-27 胃癌细胞中 KLF17 mRNA 和蛋白的水平。qPCR 和免疫组织化学分析胃癌与癌旁组织中表达的差异。划痕愈合和 Transwell 小室实验分析 BGC-823 和 HGC-27 细胞中过表达对侵袭/迁移的影响。qPCR 和蛋白质印迹法分析 BGC-823 和 HGC-27 细胞转染前后 KLF17 和上皮-间充质转化(EMT)相关基因(基质金属蛋白酶[MMP]-9、波形蛋白和 E-钙黏蛋白)的表达变化。qPCR 和蛋白质印迹法评估 BGC-823 和 HGC-27 细胞中转化生长因子(TGF)-β1、Smad 家族成员(Smad)2/3 和磷酸化-Smad2/3 的水平。
与癌旁组织相比,胃癌组织中表达降低,与 GES-1 正常胃黏膜细胞相比,胃癌细胞系中表达降低,且与癌细胞分化程度呈正相关。划痕愈合和 Transwell 实验显示,过表达的 BGC-823 和 HGC-27 细胞迁移和侵袭能力降低。BGC-823 和 HGC-27 癌细胞中过表达与 MMP-9 和波形蛋白降低,KLF17 和 E-钙黏蛋白增加有关。BGC-823 和 HGC-27 癌细胞中 TGF-β1 和 p-Smad2/3 水平降低与过表达有关。
在胃癌组织和细胞系中表达水平较低。过表达可能通过 TGF-β/Smad 通路抑制 EMT,从而降低胃癌细胞的侵袭和迁移。因此,KLF17 可能成为治疗胃癌的新靶点。